Crossmark

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients

Crossref DOI link: https://doi.org/10.1007/s40120-023-00474-9

Published Online: 2023-04-06

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Santoro, Jonathan D. https://orcid.org/0000-0002-8350-8234
Gould, Jennifer

Panahloo, Zoya

Thompson, Ella

Lefelar, Julia

Palace, Jacqueline
Funding

Funding for this research was provided by:

UCB Pharma
License Information

Text and Data Mining valid from 2023-04-06

Version of Record valid from 2023-04-06
More Information

Article History

Received: 16 January 2023

Accepted: 23 March 2023

First Online: 6 April 2023

Change Date: 10 May 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40120-023-00490-9

Updates are available Correction dated 2023-05-10

Click to view Correction: https://doi.org/10.1007/s40120-023-00490-9